多节段后路腰椎融合术中伤口浸润麻醉加用酮咯酸:一项随机双盲安慰剂对照试验
该随机双盲安慰剂对照试验纳入47例多节段腰椎减压后外侧融合患者,比较0.5%布比卡因伤口浸润加用30 mg酮咯酸与单用布比卡因的镇痛效果。结果显示,酮咯酸组术后6小时背痛NRS评分低于对照组,且术后24至96小时吗啡消耗量均较少,两组术后并发症无差异。
要点
- 多节段后路腰椎融合伤口浸润时,布比卡因加用30 mg酮咯酸可降低术后6小时背痛NRS评分。
- 酮咯酸组术后24、48、72、96小时吗啡消耗量均低于对照组。
- 两组术后并发症无差异。
核心结论
- 后路腰椎减压融合术后伤口浸润时,布比卡因加用酮咯酸较单用布比卡因可减轻早期术后疼痛并减少吗啡总消耗量。
研究设计与样本
- 随机双盲安慰剂对照试验,纳入多节段腰椎减压后外侧融合患者,随机分为对照组(0.5%盐酸布比卡因伤口旁肌肉注射)和酮咯酸组(加用30 mg酮咯酸),共47例(酮咯酸组24例,对照组23例),平均年龄60.9±6.9岁。
主要发现
- 术后6小时背痛NRS评分对照组为5.8±3.0分,酮咯酸组为3.3±2.1分(P<0.01)。
- 酮咯酸组较对照组吗啡消耗量在术后24小时少9.1 mg,48小时少13.8 mg,72小时少14.3 mg,96小时少13.9 mg(P<0.05)。
- 两组术后并发症无差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Randomized double-blind controlled trial. OBJECTIVE: The purpose of this study was to determine the efficacy of pain control and opioid consumption after administration of ketorolac directly to paraspinal muscle after spinal fusion. SUMMARY OF BACKGROUND DATA: Ketorolac is added to multimodal analgesia regimens to improve pain control, reduce opioid consumption following orthopaedics and spine surgery. However, evidence of the efficacy of adding ketorolac to local anesthesia for intrawound infiltration after spine surgery is still limited. MATERIALS AND METHODS: The patients who underwent multilevel lumbar decompression and posterolateral fusion were recruited and randomized to the control group which received 0.5% bupivacaine hydrochloride injected into paraspinal muscles before wound closure, and the ketorolac group which received 30 mg ketorolac in addition to 0.5% bupivacaine hydrochloride. Postoperative numerical rating scale (NRS) for back pain, leg pain, morphine consumption, and adverse events were recorded. RESULTS: A total of 47 patients were randomized (24 in the ketorolac group and 23 in the control group). The mean age was 60.9±6.9 years old. The mean NRS for back pain at 6 hours after surgery was 5.8±3.0 points for the control group and 3.3±2.1 points for the ketorolac group ( P <0.01). The ketorolac group consumed lesser morphine than the control group by 9.1 mg in the first 24 hours, 13.8 mg at 48 hours, 14.3 mg at 72 hours, and 13.9 mg at 96 hours after the surgery ( P <0.05). Postoperative complications were not different between the two groups. CONCLUSIONS: The addition of ketorolac to bupivacaine for wound infiltration after posterior lumbar spine decompression and fusion reduces early postoperative pain and total morphine consumption as compared with bupivacaine alone.
引用
- Chaibhuddanugul N, Weerakul S, Laoruengthana A, et al. Addition of Ketorolac to Local Anesthesia for Wound Infiltration in Multilevel Posterior Lumbar Spinal Fusion: A Randomized, Double-Blinded, Placebo-Controlled Trial. Spine (Phila Pa 1976). 2024. PMID: 38556707. doi:10.1097/BRS.0000000000004998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。